Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Intracellular invasion and survival of Brucella neotomae, another possible zoonotic Brucella species.

Waldrop SG, Sriranganathan N.

PLoS One. 2019 Apr 3;14(4):e0213601. doi: 10.1371/journal.pone.0213601. eCollection 2019.

2.

Overexpression of wbkF gene in Brucella abortus RB51WboA leads to increased O-polysaccharide expression and enhanced vaccine efficacy against B. abortus 2308, B. melitensis 16M, and B. suis 1330 in a murine brucellosis model.

Dabral N, Burcham GN, Jain-Gupta N, Sriranganathan N, Vemulapalli R.

PLoS One. 2019 Mar 11;14(3):e0213587. doi: 10.1371/journal.pone.0213587. eCollection 2019.

3.

Development of an auxotrophic, live-attenuated Brucella suis vaccine strain capable of expressing multimeric GnRH.

Smith GP, Jain-Gupta N, Alqublan H, Dorneles EMS, Boyle SM, Sriranganathan N.

Vaccine. 2019 Feb 8;37(7):910-914. doi: 10.1016/j.vaccine.2018.12.070. Epub 2019 Jan 14.

PMID:
30655173
4.

Survival of Tomato Outbreak Associated Salmonella Serotypes in Soil and Water and the Role of Biofilms in Abiotic Surface Attachment.

Dev Kumar G, Williams RC, Sriranganathan N, Boyer RR, Eifert JD.

Foodborne Pathog Dis. 2018 Sep;15(9):548-553. doi: 10.1089/fpd.2017.2416. Epub 2018 Jul 16.

PMID:
30010397
5.

Genetically engineered oncolytic Newcastle disease virus mediates cytolysis of prostate cancer stem like cells.

Raghunath S, Pudupakam RS, Allen A, Biswas M, Sriranganathan N.

J Biotechnol. 2017 Oct 20;260:91-97. doi: 10.1016/j.jbiotec.2017.09.015. Epub 2017 Sep 19.

PMID:
28935568
6.

Effect of copper on the up-regulation/down-regulation of genes, cytotoxicity and ion dissolution for mesoporous bioactive glasses.

Kaur G, Sriranganathan N, Waldrop SG, Sharma P, Chudasama BN.

Biomed Mater. 2017 Aug 9;12(4):045020. doi: 10.1088/1748-605X/aa7664.

PMID:
28791964
7.

Investigation of Medium Chain Fatty Acid Feed Supplementation for Reducing Salmonella Typhimurium Colonization in Turkey Poults.

Evans NP, Collins DA, Pierson FW, Mahsoub HM, Sriranganathan N, Persia ME, Karnezos TP, Sims MD, Dalloul RA.

Foodborne Pathog Dis. 2017 Sep;14(9):531-536. doi: 10.1089/fpd.2016.2273. Epub 2017 Jul 11.

8.

Rifampin Stability and Solution Concentration Enhancement Through Amorphous Solid Dispersion in Cellulose ω-Carboxyalkanoate Matrices.

Arca HÇ, Mosquera-Giraldo LI, Pereira JM, Sriranganathan N, Taylor LS, Edgar KJ.

J Pharm Sci. 2018 Jan;107(1):127-138. doi: 10.1016/j.xphs.2017.05.036. Epub 2017 Jun 7.

PMID:
28601524
9.

Airborne soil particulates as vehicles for Salmonella contamination of tomatoes.

Kumar GD, Williams RC, Al Qublan HM, Sriranganathan N, Boyer RR, Eifert JD.

Int J Food Microbiol. 2017 Feb 21;243:90-95. doi: 10.1016/j.ijfoodmicro.2016.12.006. Epub 2016 Dec 14.

PMID:
28038335
10.

Vaccination of Elk (Cervus canadensis) with Brucella abortus Strain RB51 Overexpressing Superoxide Dismutase and Glycosyltransferase Genes Does Not Induce Adequate Protection against Experimental Brucella abortus Challenge.

Nol P, Olsen SC, Rhyan JC, Sriranganathan N, McCollum MP, Hennager SG, Pavuk AA, Sprino PJ, Boyle SM, Berrier RJ, Salman MD.

Front Cell Infect Microbiol. 2016 Feb 10;6:10. doi: 10.3389/fcimb.2016.00010. eCollection 2016.

11.

Immune Response of Calves Vaccinated with Brucella abortus S19 or RB51 and Revaccinated with RB51.

Dorneles EM, Lima GK, Teixeira-Carvalho A, Araújo MS, Martins-Filho OA, Sriranganathan N, Al Qublan H, Heinemann MB, Lage AP.

PLoS One. 2015 Sep 9;10(9):e0136696. doi: 10.1371/journal.pone.0136696. eCollection 2015.

12.

Overexpression of Brucella putative glycosyltransferase WbkA in B. abortus RB51 leads to production of exopolysaccharide.

Dabral N, Jain-Gupta N, Seleem MN, Sriranganathan N, Vemulapalli R.

Front Cell Infect Microbiol. 2015 Jun 24;5:54. doi: 10.3389/fcimb.2015.00054. eCollection 2015.

13.

Recent advances in Brucella abortus vaccines.

Dorneles EM, Sriranganathan N, Lage AP.

Vet Res. 2015 Jul 8;46:76. doi: 10.1186/s13567-015-0199-7. Review.

14.

Review and the state of the art: Sol-gel and melt quenched bioactive glasses for tissue engineering.

Kaur G, Pickrell G, Sriranganathan N, Kumar V, Homa D.

J Biomed Mater Res B Appl Biomater. 2016 Aug;104(6):1248-75. doi: 10.1002/jbm.b.33443. Epub 2015 Jun 9. Review.

PMID:
26060931
15.

Immune response triggered by Brucella abortus following infection or vaccination.

Dorneles EM, Teixeira-Carvalho A, Araújo MS, Sriranganathan N, Lage AP.

Vaccine. 2015 Jul 17;33(31):3659-66. doi: 10.1016/j.vaccine.2015.05.057. Epub 2015 Jun 3. Review.

PMID:
26048781
16.

Roles of bacterial membrane vesicles.

Avila-Calderón ED, Araiza-Villanueva MG, Cancino-Diaz JC, López-Villegas EO, Sriranganathan N, Boyle SM, Contreras-Rodríguez A.

Arch Microbiol. 2015 Jan;197(1):1-10. doi: 10.1007/s00203-014-1042-7. Epub 2014 Oct 8. Review.

PMID:
25294190
17.

Oral immunization of mice with gamma-irradiated Brucella neotomae induces protection against intraperitoneal and intranasal challenge with virulent B. abortus 2308.

Dabral N, Martha-Moreno-Lafont, Sriranganathan N, Vemulapalli R.

PLoS One. 2014 Sep 16;9(9):e107180. doi: 10.1371/journal.pone.0107180. eCollection 2014.

18.

T lymphocytes subsets and cytokine pattern induced by vaccination against bovine brucellosis employing S19 calfhood vaccination and adult RB51 revaccination.

Dorneles EM, Teixeira-Carvalho A, Araújo MS, Lima GK, Martins-Filho OA, Sriranganathan N, Lage AP.

Vaccine. 2014 Oct 21;32(46):6034-8. doi: 10.1016/j.vaccine.2014.08.060. Epub 2014 Sep 10.

PMID:
25218192
19.

Electroporation-based delivery of cell-penetrating peptide conjugates of peptide nucleic acids for antisense inhibition of intracellular bacteria.

Ma S, Schroeder B, Sun C, Loufakis DN, Cao Z, Sriranganathan N, Lu C.

Integr Biol (Camb). 2014 Oct;6(10):973-8. doi: 10.1039/c4ib00172a.

PMID:
25160797
20.

Electroporation-delivered fluorescent protein biosensors for probing molecular activities in cells without genetic encoding.

Sun C, Ouyang M, Cao Z, Ma S, Alqublan H, Sriranganathan N, Wang Y, Lu C.

Chem Commun (Camb). 2014 Oct 9;50(78):11536-9. doi: 10.1039/c4cc04730c.

21.

Experimental comparison of hemolytic and nonhemolytic Ornithobacterium rhinotracheale field isolates in vivo.

Walters J, Evans R, LeRoith T, Sriranganathan N, McElroy A, Pierson FW.

Avian Dis. 2014 Mar;58(1):78-82.

PMID:
24758117
22.

Proteomic analysis of detergent resistant membrane domains during early interaction of macrophages with rough and smooth Brucella melitensis.

Lauer SA, Iyer S, Sanchez T, Forst CV, Bowden B, Carlson K, Sriranganathan N, Boyle SM.

PLoS One. 2014 Mar 18;9(3):e91706. doi: 10.1371/journal.pone.0091706. eCollection 2014.

23.

Synthesis, cytotoxicity, and hydroxyapatite formation in 27-Tris-SBF for sol-gel based CaO-P2O5-SiO2-B2O3-ZnO bioactive glasses.

Kaur G, Pickrell G, Kimsawatde G, Homa D, Allbee HA, Sriranganathan N.

Sci Rep. 2014 Mar 18;4:4392. doi: 10.1038/srep04392.

24.

Immunotherapeutics to prevent the replication of Brucella in a treatment failure mouse model.

Jain-Gupta N, Contreras-Rodriguez A, Smith GP, Garg VK, Witonsky SG, Isloor S, Vemulapalli R, Boyle SM, Sriranganathan N.

Vaccine. 2014 Feb 12;32(8):918-23. doi: 10.1016/j.vaccine.2013.12.058. Epub 2014 Jan 4.

PMID:
24397905
25.

Studying the activity of antitubercluosis drugs inside electrospun polyvinyl alcohol, polyethylene oxide, and polycaprolacton nanofibers.

Hassounah IA, Shehata NA, Kimsawatde GC, Hudson AG, Sriranganathan N, Joseph EG, Mahajan RL.

J Biomed Mater Res A. 2014 Nov;102(11):4009-16. doi: 10.1002/jbm.a.35070. Epub 2014 Jan 9.

PMID:
24376010
26.

Interplay of degradation, dissolution and stabilization of clarithromycin and its amorphous solid dispersions.

Pereira JM, Mejia-Ariza R, Ilevbare GA, McGettigan HE, Sriranganathan N, Taylor LS, Davis RM, Edgar KJ.

Mol Pharm. 2013 Dec 2;10(12):4640-53. doi: 10.1021/mp400441d. Epub 2013 Oct 29.

PMID:
24116899
27.

A review of Brucella seroprevalence among humans and animals in Bangladesh with special emphasis on epidemiology, risk factors and control opportunities.

Islam MA, Khatun MM, Werre SR, Sriranganathan N, Boyle SM.

Vet Microbiol. 2013 Oct 25;166(3-4):317-26. doi: 10.1016/j.vetmic.2013.06.014. Epub 2013 Jun 29. Review.

PMID:
23867082
28.

A history of the development of Brucella vaccines.

Avila-Calderón ED, Lopez-Merino A, Sriranganathan N, Boyle SM, Contreras-Rodríguez A.

Biomed Res Int. 2013;2013:743509. doi: 10.1155/2013/743509. Epub 2013 Jun 3. Review.

29.

Protection to respiratory challenge of Brucella abortus strain 2308 in the lung.

Surendran N, Sriranganathan N, Boyle SM, Hiltbold EM, Tenpenny N, Walker M, Zimmerman K, Werre S, Witonsky SG.

Vaccine. 2013 Aug 28;31(38):4103-10. doi: 10.1016/j.vaccine.2013.06.078. Epub 2013 Jul 8.

PMID:
23845817
30.

Peptide nucleic acids inhibit growth of Brucella suis in pure culture and in infected murine macrophages.

Rajasekaran P, Alexander JC, Seleem MN, Jain N, Sriranganathan N, Wattam AR, Setubal JC, Boyle SM.

Int J Antimicrob Agents. 2013 Apr;41(4):358-62. doi: 10.1016/j.ijantimicag.2012.11.017. Epub 2013 Jan 8.

31.

Magnetic Nanoclusters with Hydrophilic Spacing for Dual Drug Delivery and Sensitive Magnetic Resonance Imaging.

Pothayee N, Balasubramaniam S, Pothayee N, Jain N, Hu N, Lin Y, Davis RM, Sriranganathan N, Koretsky AP, Riffle JS.

J Mater Chem B. 2013;1(8):1142-1149.

32.

Infection cycle of Salmonella enterica serovar Enteritidis in latent carrier mice.

Maciel BM, Sriranganathan N, Romano CC, dos Santos TF, Teixeira Dias JC, Gross E, Rezende RP.

Can J Microbiol. 2012 Dec;58(12):1389-95. doi: 10.1139/cjm-2012-0375. Epub 2012 Nov 27.

PMID:
23210996
33.

Pluronic P85 enhances the efficacy of outer membrane vesicles as a subunit vaccine against Brucella melitensis challenge in mice.

Jain-Gupta N, Contreras-Rodriguez A, Vemulapalli R, Witonsky SG, Boyle SM, Sriranganathan N.

FEMS Immunol Med Microbiol. 2012 Dec;66(3):436-44. doi: 10.1111/1574-695X.12010.

34.

Effect of exogenous erythritol on growth and survival of Brucella.

Jain N, Boyle SM, Sriranganathan N.

Vet Microbiol. 2012 Dec 7;160(3-4):513-6. doi: 10.1016/j.vetmic.2012.06.014. Epub 2012 Jun 20.

PMID:
22784921
35.

Nanomedicine for intracellular therapy.

Ranjan A, Pothayee N, Seleem MN, Boyle SM, Kasimanickam R, Riffle JS, Sriranganathan N.

FEMS Microbiol Lett. 2012 Jul;332(1):1-9. doi: 10.1111/j.1574-6968.2012.02566.x. Epub 2012 May 3. Review.

36.

Isolation, mouse pathogenicity, and genotyping of Trypanosoma cruzi from an English Cocker Spaniel from Virginia, USA.

Patel JM, Rosypal AC, Zimmerman KL, Monroe WE, Sriranganathan N, Zajac AM, Yabsley MJ, Lindsay DS.

Vet Parasitol. 2012 Jul 6;187(3-4):394-8. doi: 10.1016/j.vetpar.2012.01.031. Epub 2012 Jan 28.

PMID:
22341614
37.

Characterization of outer membrane vesicles from Brucella melitensis and protection induced in mice.

Avila-Calderón ED, Lopez-Merino A, Jain N, Peralta H, López-Villegas EO, Sriranganathan N, Boyle SM, Witonsky S, Contreras-Rodríguez A.

Clin Dev Immunol. 2012;2012:352493. doi: 10.1155/2012/352493. Epub 2011 Dec 29.

38.

Role of TLRs in Brucella mediated murine DC activation in vitro and clearance of pulmonary infection in vivo.

Surendran N, Hiltbold EM, Heid B, Akira S, Standiford TJ, Sriranganathan N, Boyle SM, Zimmerman KL, Makris MR, Witonsky SG.

Vaccine. 2012 Feb 14;30(8):1502-12. doi: 10.1016/j.vaccine.2011.12.036. Epub 2012 Jan 9.

PMID:
22234268
39.

Detection of Salmonella Enteritidis in asymptomatic carrier animals: comparison of quantitative real-time PCR and bacteriological culture methods.

Maciel BM, Dias JC, Romano CC, Sriranganathan N, Brendel M, Rezende RP.

Genet Mol Res. 2011 Oct 24;10(4):2578-88. doi: 10.4238/2011.October.24.1.

40.

Proinflammatory caspase-2-mediated macrophage cell death induced by a rough attenuated Brucella suis strain.

Chen F, Ding X, Ding Y, Xiang Z, Li X, Ghosh D, Schurig GG, Sriranganathan N, Boyle SM, He Y.

Infect Immun. 2011 Jun;79(6):2460-9. doi: 10.1128/IAI.00050-11. Epub 2011 Apr 4.

41.

Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.

Rajasekaran P, Surendran N, Seleem MN, Sriranganathan N, Schurig GG, Boyle SM.

Vaccine. 2011 Apr 12;29(17):3106-10. doi: 10.1016/j.vaccine.2011.02.054. Epub 2011 Mar 3.

PMID:
21376799
42.

Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice.

Surendran N, Sriranganathan N, Lawler H, Boyle SM, Hiltbold EM, Heid B, Zimmerman K, Witonsky SG.

Vaccine. 2011 Mar 24;29(15):2749-55. doi: 10.1016/j.vaccine.2011.01.090. Epub 2011 Feb 20.

PMID:
21316499
43.

Effect of entF deletion on iron acquisition and erythritol metabolism by Brucella abortus 2308.

Jain N, Rodriguez AC, Kimsawatde G, Seleem MN, Boyle SM, Sriranganathan N.

FEMS Microbiol Lett. 2011 Mar;316(1):1-6. doi: 10.1111/j.1574-6968.2010.02186.x. Epub 2011 Jan 10.

44.

Identification of a single-nucleotide insertion in the promoter region affecting the sodC promoter activity in Brucella neotomae.

Moustafa DA, Jain N, Sriranganathan N, Vemulapalli R.

PLoS One. 2010 Nov 24;5(11):e14112. doi: 10.1371/journal.pone.0014112.

45.

Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challenge.

Moustafa D, Garg VK, Jain N, Sriranganathan N, Vemulapalli R.

Vaccine. 2011 Jan 17;29(4):784-94. doi: 10.1016/j.vaccine.2010.11.018. Epub 2010 Nov 23.

46.

Heat-killed and γ-irradiated Brucella strain RB51 stimulates enhanced dendritic cell activation, but not function compared with the virulent smooth strain 2308.

Surendran N, Hiltbold EM, Heid B, Sriranganathan N, Boyle SM, Zimmerman KL, Witonsky SG.

FEMS Immunol Med Microbiol. 2010 Nov;60(2):147-55. doi: 10.1111/j.1574-695X.2010.00729.x. Epub 2010 Aug 31.

47.

Ability of Brucella abortus rough vaccine strains to elicit DC and innate immunity in lung using a murine respiratory model.

Surendran N, Zimmerman K, Seleem MN, Sriranganathan N, Boyle SM, Hiltbold EM, Lawler H, Heid B, Witonsky SG.

Vaccine. 2010 Oct 8;28(43):7009-15. doi: 10.1016/j.vaccine.2010.08.039. Epub 2010 Aug 18.

PMID:
20727395
48.

Live Brucella abortus rough vaccine strain RB51 stimulates enhanced innate immune response in vitro compared to rough vaccine strain RB51SOD and virulent smooth strain 2308 in murine bone marrow-derived dendritic cells.

Surendran N, Hiltbold EM, Heid B, Sriranganathan N, Boyle SM, Zimmerman KL, Makris MR, Witonsky SG.

Vet Microbiol. 2011 Jan 10;147(1-2):75-82. doi: 10.1016/j.vetmic.2010.06.001. Epub 2010 Jun 10.

PMID:
20594772
49.

Efficacy of amphiphilic core-shell nanostructures encapsulating gentamicin in an in vitro salmonella and listeria intracellular infection model.

Ranjan A, Pothayee N, Vadala TP, Seleem MN, Restis E, Sriranganathan N, Riffle JS, Kasimanickam R.

Antimicrob Agents Chemother. 2010 Aug;54(8):3524-6. doi: 10.1128/AAC.01522-09. Epub 2010 Jun 1.

50.

Tightly regulated expression vectors for Ochrobactrum anthropi.

Alqublan H, Seleem MN, Boyle SM, Sriranganathan N.

Curr Microbiol. 2010 Apr;60(4):242-7. doi: 10.1007/s00284-009-9532-6. Epub 2010 Mar 17.

PMID:
20237980

Supplemental Content

Loading ...
Support Center